Genetic tests, most commonly BRCA1/2 (59, 40%), Lynch syndrome (23; 16%), and the newborn screening panel (18; 12%) (Table 2), were offered in 145/148 genetic programs. The gene discussed is BRCA1; the disease is Lynch syndrome.